Share This Article

Facebook LinkedIn
Twitter Reddit
Print Email
Pinterest Gmail
Yahoo
Money Morning
×
  • Invest
    • Best Stocks to Buy
    • Stock Forecasts
    • Stocks to Sell Now
    • Stock Market Predictions
    • Technology Stocks
    • Best REITs to Buy Now
    • IPO Stocks
    • Penny Stocks
    • Dividend Stocks
    • Cryptocurrencies
    • Cannabis Investing
    • AI Investing
  • Trade
    • How to Trade Options
    • Best Trades to Make Now
    • Options Trading Strategies
    • Weekly Trade Recommendations
  • Retire
    • Income Investing Guide
    • Retirement Articles
  • More
    • Money Morning LIVE
    • Special Investing Reports
    • Our ELetters
    • Our Premium Services
    • Videos
    • Meet Our Experts
    • Profit Academy
    • Postcards
Login Archives Your Team About Us FAQ
  • Invest
    • Best Stocks to Buy
    • Stock Forecasts
    • Stocks to Sell Now
    • Stock Market Predictions
    • Technology Stocks
    • Best REITs to Buy Now
    • IPO Stocks
    • Penny Stocks
    • Dividend Stocks
    • Cryptocurrencies
    • Cannabis Investing
    • AI Investing
    ×
  • Trade
    • How to Trade Options
    • Best Trades to Make Now
    • Options Trading Strategies
    • Weekly Trade Recommendations
    ×
  • Retire
    • Income Investing Guide
    • Retirement Articles
    ×
  • More
    • Money Morning LIVE
    • Special Investing Reports
    • Our ELetters
    • Our Premium Services
    • Videos
    • Meet Our Experts
    • Profit Academy
    • Postcards
    ×
  • Subscribe
Enter stock ticker or keyword
×
Join 100,000+ Like-Minded Investors Today
Twitter
Tags: IPOs
Stocks: amzn, ANAB, MRK

IPO News: Is This Extremely Secretive $4.7 Billion Company About to Go Public?

By Jack Delaney, Sr. Cannabis Editor, Money Morning • March 31, 2017

View Comments

Start the conversation

Leave a Reply Click here to cancel reply.

You must be logged in to post a comment.

IPO News: There's a massive new development out of Cambridge, Mass., the home to some of the top academic minds at Harvard University and the Massachusetts Institute of Technology (MIT).

A secretive biotech company that doesn't sell any products somehow has a valuation of $4.7 billion. This stealthy startup is sitting on $1.3 billion in cash and has raised over $1.9 billion since its inception.

Little is known about the CEO other than he reportedly has a $500 million fortune.

But here's what we do know...

This private company could revolutionize modern medicine, and it may go public soon if it can successfully launch a new vaccine ...

IPO News: The Secret $4 Billion Biotech Firm with Big Plans

There are reportedly 12 drugs in its pipeline, although there are very few clues as to what the biotech firm is actually working on.IPO News

According to Forbes, the company's remedies could cure everything from cancer to the Zika virus.

In fact, well-known pharmaceutical companies are lining up to invest or work with the secretive group.

In 2013, this private business signed a deal for a $240 million cash payment with AstraZeneca Plc. (NYSE ADR: AZN), a biopharmaceutical company worth nearly $80 billion. AstraZeneca followed that with a $140 million investment in 2014.

Alexion, a rare-disease specialist, also jumped at the chance of investing with $25 million in 2014.

In June 2016, Merck & Co. Inc. (NYSE: MRK) paid $200 million to get the biotech company's help to develop cancer vaccines.

We're closely watching this company because of the success of recent healthcare IPOs.

Shares of AnaptysBio Inc. (Nasdaq: ANAB) opened at $16 per share on Jan. 2 and opened this morning at $29.17 per share.

Must Read - Spotify IPO: The Secret Way You could Make Up to 156% in Profit

That's an increase of 82% in just over two months.

Of course, finding news about the tight-lipped firm hasn't been easy. But because of an obscure lawsuit, there's more information available about the secretive company than ever before.

Here's the scoop on what could be the biggest healthcare IPO this year...

This Could Be the Biggest IPO News of 2017

Here Are 10 “One-Click” Ways to Earn 10% or Better on Your Money Every Quarter

Appreciation is great, but it’s possible to get even more out of the shares you own. A lot more: you can easily beat inflation and collect regular income to spare. There are no complicated trades to put on, no high-level options clearances necessary. In fact, you can do this with a couple of mouse clicks – passive income redefined. Click here for the report…

Claim My Free Report

Subscribe
Login
Notify of
guest

guest

1 Comment
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
Duane Zander
Duane Zander
6 years ago

A reply, a comment, a genuine interest.

0
Reply


Latest News

September 15, 2023 • By Shah Gilani

We're Headed for a Second Banking Crisis - Here's What to Do

September 14, 2023 • By Tom Gentile

Tulips Are the Secret to Trading the Next 300% Rally in AI

September 14, 2023 • By Chris Johnson

Tulips Are Telling Me How To Trade the Next 300% rally in AI
Trending Stories
ABOUT MONEY MORNING

Money Morning gives you access to a team of market experts with more than 250 years of combined investing experience – for free. Our experts – who have appeared on FOXBusiness, CNBC, NPR, and BloombergTV – deliver daily investing tips and stock picks, provide analysis with actions to take, and answer your biggest market questions. Our goal is to help our millions of e-newsletter subscribers and Moneymorning.com visitors become smarter, more confident investors.

QUICK LINKS
About Us COVID-19 Announcements How Money Morning Works FAQs Contact Us Search Article Archive Forgot Username/Password Archives Profit Academy Research Your Team Videos Text Messaging Terms of Use
FREE NEWSLETTERS
Total Wealth Research Power Profit Trades Penny Hawk Midday Momentum
PREMIUM SERVICES
Money Map Press Home Money Map Report Fast Fortune Club Weekly Cash Clock Microcurrency Trader Hyperdrive Portfolio Rocket Wealth Initiative Quantum Data Profits Flashpoint Trader Darknet Alpha Accelerators Brutus Alerts Resource Traders Alliance L.A.U.N.C.H. Investor Rob Roy Trader Long-Term Equity Profits

© 2023 Money Morning All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning.

Address: 1125 N Charles St. | Baltimore, MD, 21201 | USA | Phone: 888.384.8339 | Disclaimer | Sitemap | Privacy Policy | Whitelist Us | Do Not Sell or Share My Personal Information

wpDiscuz